SH
Samad Hussain Patanwala
About Samad Hussain Patanwala
Data last updated:
Samad Hussain Patanwala is a Director at Crystal Medicines Private Limited (since 2011) and Director at Den Mark Pharmaceuticals Private Limited (since 2021). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹198 Cr; the largest is Crystal Medicines Private Limited at ₹175 Cr (FY 2025). Earlier, Samad Hussain Patanwala was a Designated Partner at Health & More Llp (2017–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Crystal Medicines Private Limited U24230MH2004PTC148426 | Director | 21 Dec 2011 | 2004 | ₹175 Cr (FY 2025) | Active |
 Den Mark Pharmaceuticals Private Limited U24304MH2021PTC372188 | Director | 25 Nov 2021 | 2021 | ₹23.71 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Health & More Llp AAI-8131 | Designated Partner | 10 Mar 2017 | 2017 | ₹4 Lakh (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Samad Hussain Patanwala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abdul Shakoor Abdul Gafoor Shaikh | 02167289 | Crystal Medicines Private Limited | Director |
| Fahad Hussain Patanwala | 07733420 | Crystal Medicines Private Limited | Director |
| Hussain Yusuf Patanwala | 02167269 | Crystal Medicines Private Limited | Director |
| Rashida Hussain Patanwala | 05313307 | Crystal Medicines Private Limited | Director |
| Shahnazar | 07359481 | Den Mark Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Samad Hussain Patanwala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samad Hussain Patanwala
Samad Hussain Patanwala currently holds 2 directorships: Crystal Medicines Private Limited (Director, since 21 Dec 2011, revenue ₹175 Cr (FY 2025)); Den Mark Pharmaceuticals Private Limited (Director, since 25 Nov 2021, revenue ₹23.71 Cr (FY 2024)).
Samad Hussain Patanwala was first appointed on 21 Dec 2011 as Director at Crystal Medicines Private Limited. The most recent appointment on record is 25 Nov 2021 at Den Mark Pharmaceuticals Private Limited.
The 2 current companies of Samad Hussain Patanwala that report revenue have a combined latest revenue of ₹198 Cr: Crystal Medicines Private Limited ₹175 Cr (FY 2025); Den Mark Pharmaceuticals Private Limited ₹23.71 Cr (FY 2024).
Samad Hussain Patanwala held 1 earlier board appointment: Health & More Llp (Designated Partner, 10 Mar 2017 to 31 Jul 2020).
The current boards of Samad Hussain Patanwala's companies include Abdul Shakoor Abdul Gafoor Shaikh (Crystal Medicines Private Limited), Fahad Hussain Patanwala (Crystal Medicines Private Limited), Hussain Yusuf Patanwala (Crystal Medicines Private Limited), Rashida Hussain Patanwala (Crystal Medicines Private Limited), Shahnazar (Den Mark Pharmaceuticals Private Limited).